Drug Type Small molecule drug |
Synonyms BFC 1108, BFC1108 |
Target |
Action modulators |
Mechanism Bcl-2 modulators(Apoptosis regulator Bcl-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H21ClN2O4 |
InChIKeyKSBAFMQAXIHVCL-UHFFFAOYSA-N |
CAS Registry692774-37-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Triple Negative Breast Cancer | Preclinical | United States | 04 Mar 2024 |





